Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more
Imricor Medical Systems Inc (IMR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.198x
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has a cash flow conversion efficiency ratio of -0.198x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.56 Million) by net assets (AU$23.08 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imricor Medical Systems Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Imricor Medical Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Imricor Medical Systems Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imricor Medical Systems Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dap Gayrimenkul Gelistirme AS
IS:DAPGM
|
0.038x |
|
Auto Partner SA
WAR:APR
|
-0.001x |
|
China Western Power Industrial Co Ltd
SHE:002630
|
0.012x |
|
Fujian Forecam Optics Co Ltd
SHG:688010
|
-0.020x |
|
Star Gas Partners LP
NYSE:SGU
|
0.046x |
|
Kopin Corporation
NASDAQ:KOPN
|
-0.005x |
|
Omnijoi Media Corp
SHE:300528
|
0.124x |
|
Van Phu - Invest Investment JSC
VN:VPI
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Imricor Medical Systems Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Imricor Medical Systems Inc from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$-7.38 Million | AU$-15.57 Million | 2.111x | +42.40% |
| 2023-12-31 | AU$-8.75 Million | AU$-12.98 Million | 1.483x | +167.44% |
| 2022-12-31 | AU$7.51 Million | AU$-16.51 Million | -2.198x | -181.58% |
| 2021-12-31 | AU$22.40 Million | AU$-17.49 Million | -0.781x | -83.94% |
| 2020-12-31 | AU$28.82 Million | AU$-12.23 Million | -0.424x | +54.96% |
| 2019-12-31 | AU$7.03 Million | AU$-6.63 Million | -0.942x | -100.20% |
| 2018-12-31 | AU$13.47 Million | AU$-6.34 Million | -0.471x | -143.77% |
| 2017-12-31 | AU$-5.25 Million | AU$-5.65 Million | 1.075x | +6.98% |
| 2016-12-31 | AU$-4.03 Million | AU$-4.05 Million | 1.005x | -- |